|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Consolidated net loss | |||||
| Adjustments to reconcile consolidated net loss to net cash and cash equivalents provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Stock-based compensation expense | |||||
| Operating lease non-cash expense | |||||
| (Accretion)/amortization on marketable securities, net | |||||
| Amortization of debt issuance costs | |||||
| Impairment expense, (gain)/loss on investments and other asset sales, and other, net | |||||
| Changes in operating assets and liabilities, net of effect of acquisitions: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Deferred cost of revenue | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Developer exchange liability | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash and cash equivalents provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of property and equipment | |||||
| Payments related to business combination, net of cash acquired | |||||
| Purchases of intangible assets | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Sales of investments | |||||
| Net cash and cash equivalents used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Net proceeds from issuance of preferred stock | |||||
| Payment of withholding taxes related to net share settlement of restricted stock units | |||||
| Financing payments related to acquisitions | |||||
| Proceeds from debt issuances | |||||
| Payment of debt issuance costs | |||||
| Other financing activities | |||||
| Net cash and cash equivalents provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Property and equipment additions in accounts payable, accrued expenses and other current liabilities, and other long-term liabilities | |||||
| Intangible asset purchases in accounts payable | |||||
| Fair value of unregistered restricted stock awards issued as consideration for a business combination | |||||
| Conversion of convertible preferred stock to common stock upon direct listing | |||||
| Unpaid debt issuance costs | |||||
Loading...